We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiveing adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
- Abstract
The article offers news brief related to medicine in Great Britain. A study shows that anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients who were treated with intravenous cyclophosphamide/methotreaxate/5-flourouracil (CMF). A study assessed the feasibility of using an automated robotic technique to predict the fetal RhD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women.
- Subjects
UNITED Kingdom; MEDICINE; BREAST cancer; ANEMIA; CANCER relapse; IMMUNOGLOBULINS; PREGNANT women
- Publication
Women's Health (17455057), 2008, Vol 4, Issue 3, p216
- ISSN
1745-5057
- Publication type
Article